280 related articles for article (PubMed ID: 29747434)
1. The Impact of Human Papilloma Viruses, Matrix Metallo-Proteinases and HIV Protease Inhibitors on the Onset and Progression of Uterine Cervix Epithelial Tumors: A Review of Preclinical and Clinical Studies.
Barillari G; Monini P; Sgadari C; Ensoli B
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29747434
[TBL] [Abstract][Full Text] [Related]
2. Ritonavir or saquinavir impairs the invasion of cervical intraepithelial neoplasia cells via a reduction of MMP expression and activity.
Barillari G; Iovane A; Bacigalupo I; Palladino C; Bellino S; Leone P; Monini P; Ensoli B
AIDS; 2012 May; 26(8):909-19. PubMed ID: 22313963
[TBL] [Abstract][Full Text] [Related]
3. HIV Protease Inhibitors Block HPV16-Induced Murine Cervical Carcinoma and Promote Vessel Normalization in Association with MMP-9 Inhibition and TIMP-3 Induction.
Qiu Y; Maione F; Capano S; Meda C; Picconi O; Brundu S; Pisacane A; Sapino A; Palladino C; Barillari G; Monini P; Bussolino F; Ensoli B; Sgadari C; Giraudo E
Mol Cancer Ther; 2020 Dec; 19(12):2476-2489. PubMed ID: 33082275
[TBL] [Abstract][Full Text] [Related]
4. [Detection of high-risk human papillomavirus (HPV) E6 and E7 oncogene transcripts increases the specificity of the detection of a cervical intraepithelial neoplasia (CIN)].
Sotlar K; Diemer D; Stubner A; Menton S; Menton M; Dietz K; Wallwiener D; Bültmann B
Verh Dtsch Ges Pathol; 2005; 89():195-200. PubMed ID: 18035691
[TBL] [Abstract][Full Text] [Related]
5. Human papilloma virus (HPV) infections related to cervical intraepithelial neoplasia (CIN) and squamous cell carcinoma of the uterine cervix.
Syrjänen KJ; Syrjänen SM
Ann Clin Res; 1985; 17(2):45-56. PubMed ID: 2994541
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of MMP-9 expression by ritonavir or saquinavir is associated with inactivation of the AKT/Fra-1 pathway in cervical intraepithelial neoplasia cells.
Bacigalupo I; Palladino C; Leone P; Toschi E; Sgadari C; Ensoli B; Barillari G
Oncol Lett; 2017 May; 13(5):2903-2908. PubMed ID: 28521396
[TBL] [Abstract][Full Text] [Related]
7. Fragile histidine triad transcription abnormalities and human papillomavirus E6-E7 mRNA expression in the development of cervical carcinoma.
Segawa T; Sasagawa T; Yamazaki H; Sakaike J; Ishikawa H; Inoue M
Cancer; 1999 May; 85(9):2001-10. PubMed ID: 10223242
[TBL] [Abstract][Full Text] [Related]
8. High-risk human papillomavirus infection and E6 protein expression in lesions of the uterine cervix.
Pillai MR; Lakshmi S; Sreekala S; Devi TG; Jayaprakash PG; Rajalakshmi TN; Devi CG; Nair MK; Nair MB
Pathobiology; 1998; 66(5):240-6. PubMed ID: 9732239
[TBL] [Abstract][Full Text] [Related]
9. Entrance of the Tat protein of HIV-1 into human uterine cervical carcinoma cells causes upregulation of HPV-E6 expression and a decrease in p53 protein levels.
Barillari G; Palladino C; Bacigalupo I; Leone P; Falchi M; Ensoli B
Oncol Lett; 2016 Oct; 12(4):2389-2394. PubMed ID: 27698804
[TBL] [Abstract][Full Text] [Related]
10. HPV and Other Microbiota; Who's Good and Who's Bad: Effects of the Microbial Environment on the Development of Cervical Cancer-A Non-Systematic Review.
Läsche M; Urban H; Gallwas J; Gründker C
Cells; 2021 Mar; 10(3):. PubMed ID: 33807087
[TBL] [Abstract][Full Text] [Related]
11. HIV protease inhibitors to prevent progression of cervical intraepithelial neoplasia to cervical cancer: therapeutic opportunities and challenges.
Palefsky J
AIDS; 2012 May; 26(8):1035-6. PubMed ID: 22552478
[No Abstract] [Full Text] [Related]
12. Anti-HPV Nanoemulsified-Imiquimod: A New and Potent Formulation to Treat Cervical Cancer.
Frank LA; Gazzi RP; Mello PA; Chaves P; Peña F; Beck RCR; Buffon A; Pohlmann AR; Guterres SS
AAPS PharmSciTech; 2020 Jan; 21(2):54. PubMed ID: 31907712
[TBL] [Abstract][Full Text] [Related]
13. The ecology of human papillomavirus-induced epithelial lesions and the role of somatic evolution in their progression.
Orlando PA; Brown JS; Gatenby RA; Guliano AR
J Infect Dis; 2013 Aug; 208(3):394-402. PubMed ID: 23599315
[TBL] [Abstract][Full Text] [Related]
14. Alteration of polyunsaturated fatty acid pattern of plasma phospholipids and antioxidants in cervical HPV infection and neoplasia.
Pozzi M; Villaccio B; Picardo M; Camera E; Dicarlo A
Oncol Rep; 1997; 4(6):1243-7. PubMed ID: 21590230
[TBL] [Abstract][Full Text] [Related]
15. Manipulated microenvironment in human papilloma virus-infected epithelial cells: is the CD40-CD154 pathway beneficial for host or virus?
Shimauchi T; Piguet V
J Invest Dermatol; 2014 Dec; 134(12):2866-2868. PubMed ID: 25381767
[TBL] [Abstract][Full Text] [Related]
16. Topical Protease Inhibitor Decreases Anal Carcinogenesis in a Transgenic Mouse Model of HPV Anal Disease.
Gunder LC; Johnson HR; Yao E; Moyer TH; Green HA; Sherer N; Zhang W; Carchman EH
Viruses; 2023 Apr; 15(4):. PubMed ID: 37112993
[TBL] [Abstract][Full Text] [Related]
17. Viral proteases as therapeutic targets.
Majerová T; Konvalinka J
Mol Aspects Med; 2022 Dec; 88():101159. PubMed ID: 36459838
[TBL] [Abstract][Full Text] [Related]
18. Human Papillomavirus Modulates Matrix Metalloproteinases During Carcinogenesis: Clinical Significance and Role of Viral Oncoproteins.
Mendonça F; Teles AM; Nascimento MDDSB; Santos APAD; Lopes FF; Paiva A; Brito HO; DA Costa RG
In Vivo; 2022; 36(6):2531-2541. PubMed ID: 36309355
[TBL] [Abstract][Full Text] [Related]
19. Recurrent or primary metastatic cervical cancer: current and future treatments.
Gennigens C; Jerusalem G; Lapaille L; De Cuypere M; Streel S; Kridelka F; Ray-Coquard I
ESMO Open; 2022 Oct; 7(5):100579. PubMed ID: 36108558
[TBL] [Abstract][Full Text] [Related]
20. Multi-parametric MRI-based peritumoral radiomics on prediction of lymph-vascular space invasion in early-stage cervical cancer.
Cui L; Yu T; Kan Y; Dong Y; Luo Y; Jiang X
Diagn Interv Radiol; 2022 Jul; 28(4):312-321. PubMed ID: 35731710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
